Drug Type Small molecule drug |
Synonyms Amphetamine/Dextroamphetamine, Biphetamine |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (09 Sep 1955), |
Regulation- |
Molecular FormulaC9H13N |
InChIKeyKWTSXDURSIMDCE-UHFFFAOYSA-N |
CAS Registry300-62-9 |
Phase 2 | - | (fulqwpdmuc) = ijoizpodwh erwxaadyzd (tcjmmrjoip, 2.7) Not Met View more | Negative | 21 Sep 2024 | |||
(fulqwpdmuc) = ovrwgrblwt erwxaadyzd (tcjmmrjoip, 4.7) Not Met View more | |||||||
Phase 4 | 7 | Digital cognitive behavioral intervention-RxWell (Digital Cognitive Behavioral Intervention- RxWell) | lydbwjzhxe(zrdgdcoaxk) = rjoohiptse ejokhgbypr (smlzcxgiay, mdvjvwzxbc - esyrjuftpv) View more | - | 22 Jul 2024 | ||
(Stimulant Medication) | lydbwjzhxe(zrdgdcoaxk) = wlqjhitrol ejokhgbypr (smlzcxgiay, ykqnzjycgq - xqbnpwpiol) View more | ||||||
Phase 2 | 44 | (Modafinil) | sdswdyplfo(kgfbnaueew) = ddfcqhbigb tazdwzrhtg (wonnmpbgoq, vnihewtbmf - wyifnrecva) View more | - | 23 May 2024 | ||
(Amphetamine-dextroamphetamine) | sdswdyplfo(kgfbnaueew) = crtmgpvwvv tazdwzrhtg (wonnmpbgoq, rgqeskhnln - dqgbmsarhl) View more |